The relationship between hypoalbuminemia, systemic albumin leakage, and soluble markers of systemic inflammation and endothelial injury has been studied in peritoneal dialysis patients, with results indicating that hypoalbuminemia is more frequently associated with inflammation and atherosclerotic disease, but little is known about the use of albumin in patients with coronary artery disease [37]. This evidence concerns the gene ALB and coronary artery disorder.